Market revenue in 2023 | USD 25.4 million |
Market revenue in 2030 | USD 47.6 million |
Growth rate | 9.4% (CAGR from 2023 to 2030) |
Largest segment | Transbronchial needle aspiration (tbna) needles |
Fastest growing segment | Transbronchial Needle Aspiration (TBNA) Needles |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biopsy Forceps, Transbronchial Needle Aspiration (TBNA) Needles, Cytology Brushes |
Key market players worldwide | Olympus Corp, Boston Scientific Corp, Conmed Corp, Medtronic PLC, Becton Dickinson & Co, Hobbs Medical, Cook Medical, Telemed Systems, Argon Medical Devices, Horizons International |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bronchial biopsy devices market will help companies and investors design strategic landscapes.
Transbronchial needle aspiration (tbna) needles was the largest segment with a revenue share of 67.72% in 2023. Horizon Databook has segmented the Canada bronchial biopsy devices market based on biopsy forceps, transbronchial needle aspiration (tbna) needles, cytology brushes covering the revenue growth of each sub-segment from 2018 to 2030.
The demand for bronchial biopsy devices is expected to surge due to rising lung cancer cases, technological advancements, and improved healthcare access. According to the Canadian Cancer Society, lung cancer is the most common cancer in Canada and the leading cause of cancer death. According to the same source, in 2023, around 31,000 people were diagnosed with lung cancer.
Moreover, in 2024, around 32,100 Canadians will be diagnosed with lung and bronchus cancer. This represents 13% of all new cancer cases in 2024. Due to these rising cases, there is an increasing focus on early detection and screening for lung cancer in Canada.
The expansion of screening programs and initiatives to promote early diagnosis is expected to facilitate the demand for advanced bronchial biopsy devices. Furthermore, the presence of key players in the country is fueling market growth. Some of the market players active in the country are Olympus Corporation; Boston Scientific Corporation; Medtronic; Cook Medical; and ConMed.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada bronchial biopsy devices market , including forecasts for subscribers. This country databook contains high-level insights into Canada bronchial biopsy devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account